MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

143 hedge funds and large institutions have $502M invested in Momenta Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 53 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
143
Holders Change
-5
Holders Change %
-3.38%
% of All Funds
4.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
42
Reduced
53
Closed
21
Calls
$3.38M
Puts
$5.42M
Net Calls
-$2.04M
Net Calls Change
+$284K
Name Holding Trade Value Shares
Change
Shares
Change %
Jacobs Levy Equity Management
151
Jacobs Levy Equity Management
New Jersey
-$639K -52,890 Closed
PP
152
PDT Partners
New York
-$492K -40,704 Closed
WAM
153
Wolverine Asset Management
Illinois
-$282K -23,400 Closed
BIM
154
Bogle Investment Management
Massachusetts
-$261K -21,614 Closed
Capstone Investment Advisors
155
Capstone Investment Advisors
New York
-$192K -15,900 Closed
HCM
156
Highbridge Capital Management
New York
-$172K -14,252 Closed
DTL
157
Dynamic Technology Lab
Singapore
-$149K -12,341 Closed
SI
158
Standard Investments
New York
-$145K -12,000 Closed
PA
159
Profund Advisors
Maryland
-$131K -10,811 Closed
NIMI
160
Natixis Investment Managers International
France
-$78K -6,484 Closed
QT
161
Quantbot Technologies
New York
-$53K -4,445 Closed
VFA
162
Virtus Fund Advisers
Connecticut
-$50K -4,099 Closed
ARC
163
Absolute Return Capital
Massachusetts
-$40K -3,349 Closed
JG
164
Jefferies Group
New York
-$2K -132 Closed